Market Tracker

05/27 5:16pm ET

Cytokinetics Inc (NASDAQ:CYTK)

8.11
Delayed Data
As of May 27
 +0.03 / +0.37%
Today’s Change
5.88
Today|||52-Week Range
13.18
-22.47%
Year-to-Date
No recent news for Cytokinetics Inc.

Today’s Trading

Previous close8.08
Today’s open8.08
Day’s range7.94 - 8.15
Volume166,386
Average volume (3 months)349,531
Market cap$321.3M
Dividend yield--
Data as of 4:00pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-136.59%
Earnings growth (this year)-54.98%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-38.95%
P/E ratioNM
Price/Sales14.17
Price/Book4.68

Competitors

 Today’s
change
Today’s
% change
LJPCLa Jolla Pharmaceuti...+0.15+0.97%
RIGLRigel Pharmaceutical...-0.03-1.20%
NUTRNutraceutical Intern...+0.27+1.15%
LFVNLifeVantage Corp-0.10-0.73%
Data as of 4:00pm ET, 05/27/2016

Financials

Next reporting dateJuly 27, 2016
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$28.7M
Annual profit (last year)-$37.5M
Net profit margin-130.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert I. Blum
Chief Financial Officer, Secretary &
Executive VP
Sharon A. Barbari
Corporate headquarters
South San Francisco, California

Forecasts